Euro
USD
British Pound
NULL
Product Description
Nivolumab, trade name Opdivo, is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with Iplimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with Iplimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma.
Biovision | A2117 | Anti-PD-1 (Nivolumab) Biotinylated Antibody DataSheet
Antibody Target: PD-1
Target Alternative Name:
Tag Line: Mouse monoclonal antibody to detect biotinylated PD-1 in human samples
Category: Primary antibody
Host: Human
Isotype: IgG4
Species Reactivities: Human
Immunogen Sequence: Human programmed cell death 1 receptor (PD1)
Accession #: Q02242
Gene ID: 18566
Appearance: Colorless liquid
Form: Liquid
Concentration:
Formulation: In PBS, pH 7.2, 30% glycerol, 0.5% BSA, 0.5 mM EDTA and 0.03% proclin
Purification: Affinity purified
Application: ELISA
Positive Control:
Application And Usages: ELISA 1 µg
Country of Animal Origin: USA
Country of Manufacture: USA
Usage: For Research Use Only! Not to be used in humans.
Handling: The antibody solution should be gently mixed before use.
Western Blot Verified: FALSE
Immunocytochemistry Verified: FALSE
Immunofluorescence Verified: FALSE
Immunoprecipitation Verified: FALSE
FACS Verified: FALSE
ELISA Verified: TRUE
ChIP Verified: FALSE
Dot Blot Verified: FALSE
Flow Cytometry Verified: FALSE
